December 8, 2016 06:28 AM EST
Pharma

Seast­ead­er, drug lib­er­tar­i­an and now FDA Com­mis­sion­er? Pe­ter Thiel backs a rad­i­cal shift

John Carroll

Editor & Founder

Once Bloomberg broke the word that Pe­ter Thiel as­so­ciate Jim O’Neill was be­ing con­sid­ered for the top job at the FDA, re­porters start­ed to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times